Jorge E Torres-López, Vinicio Granados-Soto
Index: Eur. J. Pharmacol. 519(1-2) , 75-9, (2005)
Full Text: HTML
The local peripheral (subcutaneous) injection of phosphodiesterase 3 inhibitor trequinsin dose-dependently enhanced formalin-evoked flinching during late second phase of this test. Treatment with the nitric oxide synthase inhibitor N-L-nitro-arginine methyl ester or guanylyl cyclase inhibitor 1-H-[1,2,4,]oxadiazolo[4,3-a]quinoxalin-1-one significantly reversed trequinsin-induced pronociceptive effect. Results suggest that the peripheral phosphodiesterase 3 may play an important physiologic role on inflammatory pain by controlling cyclic AMP levels and therefore the nociceptor threshold.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Trequinsin hydrochloride
CAS:78416-81-6 |
C24H28ClN3O3 |
|
Pituitary adenylate cyclase activating polypeptide (PACAP) p...
1994-01-01 [Life Sci. 54(22) , 1735-43, (1994)] |
|
Atrial natriuretic peptide reduces cyclic AMP by activating ...
1994-09-01 [J. Cardiovasc. Pharmacol. 24(3) , 351-7, (1994)] |
|
Role of cGMP-inhibited phosphodiesterase and sarcoplasmic ca...
2000-10-01 [J. Mol. Cell. Cardiol. 32(10) , 1831-40, (2000)] |
|
Effects of colforsin, trequinsin and isoprenaline on norepin...
1988-02-01 [Arzneimittelforschung 38(2) , 240-3, (1988)] |
|
Dissociation between phosphodiesterase inhibition and antipr...
1997-04-25 [Biochem. Pharmacol. 53(8) , 1141-7, (1997)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
